Clinical Trial Update: Resolution of Thrombi in Left Atrial Appendage With Edoxaban [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated using edoxaban to resolve thrombi in the left atrial appendage among patients with atrial fibrillation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Left Atrial Appendage Thrombosis

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Keimyung University Dongsan Medical Center | Conditions: Atrial Fibrillation, Left Atrial Appendage Thrombosis | Phase 4 | Status: COMPLETED